Ajooni Biotech share news, announcements and annual reports
NSE: AJOONIFood ProductsSmall Cap
Ajooni Biotech Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 2018 · Issue price ₹40
Last close ₹2.87down ₹0.06 (2.05%)
Share price at the NSE close on 30 Oct 2026. Previous close ₹2.93.
30 Oct: open ₹2.90, high ₹2.95, low ₹2.86
52-week range of traded prices to 30 Oct 2026
₹2.68Low, 12 Oct 2026₹5.50High, 9 Feb 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹52 Cr3,140th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 13.14
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 4.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 4.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.19
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,11,79585.8% delivered
Ajooni Biotech share news and announcements
531 announcements, routine notices left out, newest first. Page 10 of 11.
Oct 2019
6 Oct · Board meeting
4 Oct · Updates
4 Oct · Updates
3 Oct · Meeting
Sep 2019
30 Sep · Meeting
Aug 2019
31 Aug · Board meeting
21 Aug · Board meeting
13 Aug · Board meeting
9 Aug · Board meeting
Jul 2019
9 Jul · Updates
Jun 2019
3 Jun · Legal
Exchange has sought clarification from Ajooni Biotech Limited with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. No Segment Reporting. -2. Financial results submitted is not as per format prescribed under Schedule III of the Companies Act, 2013. The response of the Company is awaited.
May 2019
29 May · Results
29 May · Board meeting
20 May · Board meeting
15 May · Board meeting
6 May · Board meeting
3 May · Legal
Exchange has sought clarification from Ajooni Biotech Limited with respect to announcement dated 25-Apr-2019, regarding Board meeting held on April 25, 2019.". On basis of above the Company is required to clarify following: 1. Whether intimated in 24hrs;2. Disclosure of relationships between directors (in case of appointment of a director);3. Brief profile (in case of appointment).The response of the Company is awaited.
Apr 2019
25 Apr · Board meeting
22 Apr · Legal
Exchange has sought clarification from Ajooni Biotech Limited with respect to announcement dated 09-Apr-2019, regarding Board meeting held on April 09, 2019. On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment)The response of the Company is awaited.17 Apr · Board meeting
9 Apr · Board meeting
6 Apr · Updates
Mar 2019
15 Mar · Board meeting
12 Mar · Board meeting
1 Mar · Legal
Exchange has sought clarification from Ajooni Biotech Limited with respect to announcement dated 15-Feb-2019, regarding Board meeting held on February 15, 2019.". On basis of above the Company is required to clarify following: 1. Date of appointment/cessation (as applicable) & term of appointmentThe response of the Company is awaited.
Feb 2019
15 Feb · Board meeting
12 Feb · Board meeting
Jan 2019
11 Jan · Board meeting
4 Jan · Board meeting